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Abstract
Mineralized biomaterials are promising for use in bone tissue engineering. Culturing osteo-
genic cells in suchmaterials will potentially generate biological bone grafts that may even fur-
ther augment bone healing. Here, we studied osteogenic differentiation of human
mesenchymal stem cells (MSC) in an alginate hydrogel systemwhere the cells were co-
immobilized with alkaline phosphatase (ALP) for gradual mineralization of the microenviron-
ment. MSC were embedded in unmodified alginate beads and alginate beads mineralized
with ALP to generate a polymer/hydroxyapatite scaffold mimicking the composition of bone.
The initial scaffold mineralization induced further mineralization of the beads with nanosized
particles, and scanning electron micrographs demonstrated presence of collagen in the min-
eralized and unmineralized alginate beads cultured in osteogenic medium. Cells in both
types of beads sustained high viability and metabolic activity for the duration of the study
(21 days) as evaluated by live/dead staining and alamar blue assay. MSC in beads induced
to differentiate in osteogenic direction expressed higher mRNA levels of osteoblast-specific
genes (RUNX2,COL1AI, SP7, BGLAP) than MSC in traditional cell cultures. Furthermore,
cells differentiated in beads expressed both sclerostin (SOST) and dental matrix protein-1
(DMP1), markers for late osteoblasts/osteocytes. In conclusion, Both ALP-modified and un-
modified alginate beads provide an environment that enhance osteogenic differentiation com-
pared with traditional 2D culture. Also, the ALP-modified alginate beads showed profound
mineralization and thus have the potential to serve as a bone substitute in tissue engineering.
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Introduction
Bone tissue engineering is the development of materials that can be used to regenerate bone in
vivo. Bone regeneration strategies can include the use of scaffolds, growth factors, cells or a
combination of the three [1]. Still, the golden standard and the most successful treatment of
bone defects are autologous bone grafts. The bone graft has osteoinductive properties through
the presence of growth factors, vascularization, and by containing cells with osteogenic poten-
tial [2]. However, bone grafts are limited in supply and associated with risk of donor site mor-
bidity and infections [3]. Hence, the use of cells with osteogenic potential in combination with
scaffolds mimicking bone is a promising alternative to bone grafts.
Mesenchymal stem cells (MSC) are cells that can differentiate into osteoblasts, adipocytes
and chondrocytes [4]. Osteoblasts produce bone matrix proteins and they also catalyze the
mineralization of bone matrix into bone. Fully mature osteoblasts have a limited life span, and
can in vivo either be terminally differentiated into osteocytes, that acts as mechanosensors in
bone, to inactive bone lining cells or they will undergo apoptosis [5]. A key step to allow surviv-
al and osteogenic differentiation of MSC in scaffolds is finding a suitable material that is bioac-
tive, non-immunogenic and that has mechanical properties similar to that of bone [6].
Materials based on extracellular components, such as collagen, are popular choices. However,
because these materials lack adequate mechanical properties and because they may stimulate
immunogenic responses after transplantation they are not ideal candidates [7]. Miscellaneous
inorganic materials such as metals (e.g. titanium) are currently used to fill bone defects and
some are used in the clinic [8]. Although such materials may prove sufficiently strong they are
poorly incorporated into existing bone and are difficult to combine with cell based tissue engi-
neering approaches. To overcome these problems recent focus has been on making composites
by combining both organic and inorganic components [9]. Important factors are the ability to
control mineral deposition and distribution to ensure that the composites to largest extent
mimic the properties of natural bone or stimulate bone formation. Although an array of poly-
mer/calcium phosphates composites have been developed, many lack the strength, and more-
over the toughness and reliability needed for bone tissue engineering [10].
Alginate is a popular candidate polymer in tissue engineering strategies. Alginate is a bio-
polymer made up by two uronic acids, mannuronate (M) and guluronate (G). Adjacent
G-monomers (G-blocks) have high affinity to divalent cations, such as Ca2+. The divalent cat-
ions crosslink G-blocks in neighboring polymers consequently forming a gel at close to physio-
logical conditions [11]. Alginate is biocompatible, non-immunogenic, thermostable and the
composition can be tailored through enzymatic modifications [12–14]. Alginate gels are in
general porous hydrogels that allow the transport of oxygen, nutrients and waste to and from
encapsulated cells [15]. Alginate gels can be made that protect transplanted cells, i.e. pancreatic
islets, against host immune cells and antibodies that allow for transplantation of allogenic and
xenogenic tissue without the need for immune protection [11, 16]. Alginate may not meet the
mechanical requirements of a bone substitute material, but the polymer's interaction with Ca2
+ forms an interesting basis for achieving better control of mineral formation in terms of crys-
tal growth rates, -size and -alignment.
Recently, we have shown that alginate can be mineralized with calcium phosphate, leading
to a homogenous and to some extent controllable deposition of mineral phase within the hy-
drogel network [17–19]. Mineralization is accomplished either by a counter diffusion method
[17] or by an enzymatic method where the enzyme alkaline phosphatase (ALP) is utilized to
liberate phosphate ions from organic phosphate compounds [19]. Both methods result in
nanocrystalline hydroxyapatite (HA) closely integrated in the alginate gel network. The latter
method is superior for cell immobilization purposes as lower concentrations of CaCl2 are
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necessary and mineralization can occur over time, as phosphate ions are gradually made avail-
able by the encapsulated ALP. In addition, enzymatic mineralization of alginate beads leads to
a homogenous distribution of mineral, as opposed to the counter diffusion method where a
core-shell distribution of mineral was most prominent [19]. The homogenously distributed
mineral was shown to provide a stiffer gel compared to core-shell mineralization, even with
lower total mineral content [18]. However, even though the Young’s modulus is higher than in
most alginate hydrogel systems [18] the modulus is still low compared with that of natural
bone. Therefore these materials are not envisaged for use in load bearing applications as such,
but would need to be combined with load bearing cell free scaffold or relay on bone develop-
ment for mechanical strength.
The fundamentally different microenvironment of a mineralized hydrogel compared to
macroporous biomaterials is an interesting feature that may be taken advantage of. Here, we in-
vestigated if bone marrow-derived MSCs could survive and differentiate in osteogenic direction
in mineralized and unmineralized alginate beads in vitro. We also aimed to compare the osteo-
genic potential of cells embedded in the mineralized and unmineralized 3D hydrogels with
cells in traditional 2D culture. Further, changes in the mineral content of the beads during the
culture period were studied.
Materials and Methods
Alginate solution
Ultrapure high-G alginate (UP MVG, batch: FP-505–01, Mw = 238.000 g/mol, [ŋ] = 1105 ml/g,
FG = 0.67, FGG = 0.56, NG1 = 13) purchased from Nova Matrix, Oslo, Norway was used to pre-
pare alginate beads. A 2.0% alginate solution was prepared of alginate in 0.9% (w/V) NaCl, pH
was adjusted to 7.2–7.4 and the solution was sterile filtered before further use.
Cell culture
Human Mesenchymal stem cells (MSCs) obtained from two different male donors (Lonza Inc,
Walkersville, MD, USA) were utilized in this study (S1 Table). The MSCs were cultured at
37°C in a humidified atmosphere containing 5% CO2 in mesenchymal stem cell growth medi-
um (Lonza). To induce osteogenic differentiation the media was added bone morphogenetic
protein 2 (BMP-2, 300ng/mL, R&D Systems, Minneapolis, MN, USA), ascorbic acid
(0.05mM), dexamethasone (10-8 M) and glycerophosphate (10mM) (hereafter called osteogen-
ic medium). Cells for differentiation purposes were used before passage 8.
Bead preparation and cell culturing
Encapsulation of cells was performed as described previously [20]. Before encapsulation of
cells, Alkaline Phosphatase (ALP, EC3.1.3.1, calf intestinal mucosa, 15 units/mg, Sigma Al-
drich, UK) was sterile filtered and mixed with the alginate solution inside a syringe to a concen-
tration of 0.25mg/ml. MSCs was added to the suspension to make a final concentration of
2 x106 cells/mL in a 1.8% alginate solution. The cell/alginate/enzyme solution was subsequently
dripped using electrostatic bead generator into a gelling solution containing CaCl2 (50mM),
NaCl (0.9% w/v) and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (10mM,
pH = 7.3). After cell encapsulation, beads were left in the gelling solution for approximately
10 minutes, prior to thorough washings in Hanks Buffered Salt Solution (HBSS, Sigma-Aldrich,
St Louis, MO). For mineralization purposes cells received MSC growth medium (Lonza Inc)
with added CaCl2 (10mM) and β-glycerophosphate (15mM, Sigma) the first 48 hours after en-
capsulation (henceforth referred to as mineralization medium)). After 48 hrs half of the
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mineralized beads were given growth medium, while the other half was given osteogenic medi-
um. Both the growth medium and osteogenic medium were added 7.5mM CaCl2 for stabiliza-
tion purposes, as mineralization results in depletion of Ca-ions from alginate gel, and as a
consequence slow gel dissolution. Cells were also encapsulated in alginate beads without the
use of ALP, and these cells were also cultured in either growth medium or osteogenic medium.
Additionally, cells were grown in culture flasks as a comparison to 3D culture. All cultures
were maintained at 5% CO2 and 37°C.
Viability and metabolic activity
Viability was assessed with a live/dead Viability Kit (Live/Dead viability/cytotoxicity kit, Invi-
trogen) according to the manufacturer’s protocol. Beads were washed in phosphate buffered sa-
line (PBS, Sigma) prior to staining. The cells in beads were then studied with Confocal Laser
Scanning Microscope (LSM 510 META FCS, Zeiss) equipped with Argon (488nm) and a HeNe
(543nm) lasers. The filters used were BP 505–530 and LP 650. Metabolic activity in the cells
was evaluated by adding alamar blue assay (Invitrogen, Thermo Fischer Scientific, Waltham,
MA, USA) by adding alamar blue reagent to a final concentration of 10% to beads correspond-
ing to 5000 cells/well in a 96 well plate. The plate was incubated for 4 hours at room tempera-
ture before measuring fluorescence using a multilabel counter (Viktor 1420; Perkin Elmer,
Wellesley, MA). The alamar blue reagent contains the weakly fluorescent indicator dye resa-
zurin, which undergoes a colorimetric change, forming the highly fluorescent resorufin upon
cellular metabolic reduction. Hence, the alamar blue assay is a non-toxic alternative to the
commonly used MTT assay [21]. Moreover, the fluorescence readout is also not influenced by
CaP minerals, which in our hands seemed to influence the absorbance readings in the MTT
assay (not shown).
Mineralization studies by LM and SEM
Mineralization of alginate beads was studied using light microscope (CKX41, Olympus). The
mineral composite structure was also studied using Scanning Electron Microscopy (SEM). To
prepare samples for SEM, beads with encapsulated cells were taken out of the culture flasks
and mixed with Tissue Tek (Qiagen). Following, the beads were frozen using acetone precooled
with liquid nitrogen in a small mould and thereafter cryo-microtomed (Leica CM 3050 S). To
prepare the sections for imaging, the samples were dried in a critical point dryer (Emitech
K850 Critical Point Dryer) and coated with 5nm Pt/Pd layer (80/20 using Cressington 208 HR
sputter coater. Sections were examined using Hitachi S5500 scanning electron microscope op-
erating at acceleration voltage of 5kV.
RNA isolation, cDNA synthesis and RT-PCR
To isolate cells the beads were dissolved by using a sequentialmethod described below as the
conventional methods for cell recovery from alginate beads have been shown to affect cell via-
bility [22]. Citrate (50mM, approximately 5mL) was added to the bead suspension and gently
vortexed for about 5 minutes. At this point, the beads that were not yet dissolved were left to
sediment to the bottom of the tube, and the rest of the suspension was pipette off and centri-
fuged (3min, 1000rpm). The remaining beads were given another 5mL of citrate and vortexed
gently before a second round of sedimentation and centrifugation. This procedure was carried
out until all beads were dissolved. Subsequently, recovered cells were washed with PBS, before
a second round of centrifugation and supernatant removal. Relative gene expression quantifi-
cation was carried out by Real-Time Quantitative PCR and TaqMan Gene Expression Reagents
(Applied Biosystems Inc, Foster City, CA, USA) following the manufacturer's instructions.
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GAPDH was used as endogenous control. The samples were run in triplicates on StepOnePlus
Real-Time PCR System (Applied Biosystems Inc, Foster City, CA, USA) and analyzed by the
Applied Step One software 2.1. The following probes were used RUNX2 (Hs00231692_m1, lot
959159), SP7 (Hs00541729_m1, lot 961822), BGLAP (Hs01587814_g1, lot 969519) COL1A1
(Hs 00164004_m1, lot 963537), DMP-1(Hs01009391_g1 lot 1048718), SOST
(Hs00228830_m1, lot 997305) and (GAPDH, Hs99999905_m1, lot 853053). Genes with a Ct
value>35 were considered as not detected.
ALP assay
ALP activity was assesed using the ELF 97 Endogenous Phosphatase Detection Kit (Molecular
Probes, Leiden, The Netherlands) according to the manufacturers protocol. At day 9 post en-
capsulation beads were dissolved in citrate (50mM) and cells were fixated and permeabilized
before addition of the phosphatase substrate. Fluorescence was measured using a multilabel
counter (Victor 1420, Perkin Elmer).
Statistical analyses
To test for significant differences between groups two-way ANOVA followed by Sidak’s or
Tukey’s multiple comparisons test was performed using GraphPad Prism version 6.00 for Mac
OS X (GraphPad Software, La Jolla California USA).
Results
Scaffold characterization
Mineralization of alginate beads can be observed by light microscopy as the beads become
more opaque and appear dark under transmitted light [17]. Hence, we examined the beads
with encapsulated MSC by light microscopy to evaluate mineralization at day 2 and 21 post en-
capsulation (Fig. 1). A total of 4 samples were studied: ALP-modified and unmodified beads
cultured in either growth medium or osteogenic medium. At day 2 post encapsulation unmodi-
fied beads appeared relatively transparent (Fig. 1A). ALP-modified beads were mineralized as
they appeared darker (Fig. 1B). Interestingly, beads which were initially ALP-modified were
then further mineralized during culture in both osteogenic medium and growth medium
(Fig. 1B). The unmodified beads, however, did only mineralize when they were cultured further
in osteogenic medium, but to a lower extent than the ALP-modified beads. These findings sug-
gest that MSC differentiate into osteogenic cells capable of inducing matrix mineralization in
both modified and unmodified alginate beads. To examine the material in the beads in more
detail, we examined beads that had been cultured for 21 days in vitro using scanning electron
microscopy (SEM) (Fig. 2) We have previously shown that mineralization of alginate hydrogels
can be characterized with SEM [17, 19]. In general, we observe mineral crystals in the samples
that appeared mineralized by light microscopy. Hence, ALP-modified beads cultured in osteo-
genic medium had highest level of mineralization, showing distinctive granular crystal mor-
phology (Fig. 2C and B). This is followed by the ALP-modified sample cultured in growth
medium (Fig. 2A) and the unmodified beads cultured in osteogenic medium, where only some
evidence of mineralization could be detected (Fig. 2D and F). In the unmodified sample cul-
tured in growth medium no crystals could be seen either in LM or SEM. (Fig. 1A and 2B).
Cell viability and metabolic activity
Viability of the encapsulated cells was high after encapsulation and remained high with an esti-
mated 90% viability for the duration of the study, as examined by visual inspection of live/dead
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Fig 1. Mineralization of alginate beads. Light microscopy of unmodified (A) or ALP-modified (B) beads taken at day 2 and day 21 post encapsulation. Cells
were cultured in either growth medium (GM) or osteogenic medium (OM). Mineralized beads appear dark whereas unmineralized beads appear transparent.
Scale bar 500μm.
doi:10.1371/journal.pone.0120374.g001
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staining by confocal microscopy (Fig. 3A). Moreover, no significant differences in viability
were observed for the different sample groups (Fig. 3A and S1 Fig.). The metabolic activity
measured by Alamar Blue assay increased over time for cells in both types of beads cultured in
either OM and GM which further support that the cells survive in the beads, and might also
suggest that the cells divide during the culture period (Fig. 3B). The metabolic activity appeared
Fig 2. SEMmicrographs of the alginate network in ALP-modified (A, C, E) or unmodified (B, D, F) beads taken at day 21 post encapsulation. Cells
were cultured in either growth medium (A, B) or osteogenic medium (C-F). Mineral particles with spherical morphology are clearly visible for heavily
mineralized samples shown at high and low magnification in panel C and E.
doi:10.1371/journal.pone.0120374.g002
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Fig 3. Viability of hMSCs in alginate beads cultured in osteogenicmedium. (A) Live/dead fluorescent staining of cells cultured in osteogenic medium
was visualized using confocal microscopy (LSM 510 META FCS, Zeiss). Left images: Confocal cross sections through overlaid transmitted light of hMSCs in
alginate beads; Right images: three dimensional reconstructions of cross sections through the beads. Live cells appear green, dead cells appear red. Scale
bar 500 μm. (B)Metabolic activity of MSC in alginate beads cultured in growth medium (GM) or osteogenic medium (OM) at day 2, 7, 14 and 21 post
encapsulation measured by Alamar Blue assay. Metabolic activity was significantly different in ALPmodified beads cultured in OM compared with
unmodified beads cultured in OM at day 14, p<0.001, day 17, p< = 0.01 and day 21, p< = 0.001, Sidak’s multiple comparison test. The difference in
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PLOS ONE | DOI:10.1371/journal.pone.0120374 March 13, 2015 8 / 16
higher in cells cultured in growth medium compared with cells cultured in osteogenic medium,
although the difference was only statistically significant at day 14 for cells cultured in unmodi-
fied beads (p 0.05, Sidak’s multiple comparison test). The lower metabolic activity in cells cul-
tured in OMmight reflect a lower number of cells, as differentiated osteoblasts rarely divide
compared with the more immature cells [23]. There was no significant difference in metabolic
activity between cells cultured in GM in unmodified versus ALP-modified beads. However, at
day 7, 14 and 21 after encapsulation, cells cultured in OM had a significantly higher metabolic
activity in ALP-modified beads compared with cells in unmodified beads (p 0.001, p 0.01,
p 0.001, respectively, Sidak’s multiple comparison test). In conclusion, encapsulation of
hMSC in mineralized and unmineralized alginate beads maintain high viability and
metabolic activity.
Collagen production
To investigate whether the cells influenced the material properties during the culture period by
e.g. secreting matrix proteins, beads from all 4 sample groups and cells from traditional culture
plate (2D) samples were examined by SEM after 21days of culture. SEMmicroscopy revealed
that cells in both ALP-modified (Fig. 4A and C) and unmodified alginate beads (Fig. 4B and D)
cultured in osteogenic medium produce significant amounts of well organized, fibrillar colla-
gen, which seemed to be located in the pericellular space between the cell surface and the algi-
nate matrix (Fig. 4). The fibrils had diameters in the range of 100 nm and showed periodicity
of 60–70 nm along the fibril axis typical for collagen type I (Fig. 4C and D). [24–26]. We did
not observe collagen fibrils in beads cultured in growth medium (data not shown) suggesting
that the 3D environment itself was not sufficient to promote collagen production. In the sam-
ple cultured in osteogenic medium on traditional culture plate (2D) no collagen fibrils was ob-
served neither, but this could be due to it being washed away during media change or due to
sample preparation for SEM (data not shown).
Differentiation
To characterize the differentiation stage of the encapsulated cells, mRNA expression of mark-
ers for osteoblast differentiation were examined at day 7, 14 and 21 post encapsulation. As a
reference the gene expression levels in MSC cultured on tissue culture plates in osteogenic
media for 7, 14 and 21 days were also quantified. RUNX2 is considered an early osteoblastic
gene [27], and we found RUNX2 to be expressed in all samples (Fig. 5A). RUNX2 mRNA was
significantly higher in ALP-modified beads cultured in GM compared with unmodified beads
cultured in GM (p 0.001, all time points, Tukey’s multiple comparison test). However, there
was no significant difference in RUNX2 expression in the different bead types cultured in OM.
The expression of the transcription factor osterix (SP7) increases during osteoblast maturation
[28]. We found that SP7 was induced in cells cultured in traditional 2D in osteogenic medium;
still, SP7 expression was higher in cells cultured in OM in the two bead types compared with
cells cultured in 2D (p 0.001, both bead types, all time points, Tukey’s multiple comparison
test). In comparison, SP7 expression in cells cultured in beads in GM was low, suggesting that a
3D environment by itself is not sufficient to promote the differentiation of fully mature osteo-
blasts (Fig. 5B). Collagen type I (COL1A1) is the major matrix protein produced by osteoblasts.
Strikingly, cells cultured in osteogenic medium in both ALP-modified and non-modified
metabolic activity between unmodified and ALP-modified beads cultured in GM was not statistically significant. The data presented are mean values +/- SD,
n = 3. ALP: Containing 0.25mg/mL ALP.
doi:10.1371/journal.pone.0120374.g003
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alginate beads expressed higher levels of collagen type I than cells cultured in the same medium
in traditional 2D, suggesting that a 3D environment might promote collagen type I expression
(Tukey’s multiple comparison test p 0.001 for both bead types) (Fig. 5C). At day 14, COL1A1
was higher in unmodified beads compared with ALP-modified beads for cells cultured in OM
(p 0.001, Tukey’s multiple comparison test) but in cells cultured in growth media COL1A1
mRNA expression was similar in the two bead types. Similarly, gene expression levels of osteo-
calcin (bone gamma-carboxyglutamic acid-containing protein (BGLAP)) a secreted protein
produced by mature osteoblasts, were higher in cells cultured in osteogenic medium in 3D
compared with cells cultured in osteogenic medium in traditional 2D culture, in which we
could not detect BGLAPmRNA (Fig. 5D). There was no difference in BGLAPmRNA expres-
sion between cells cultured in GM in the two bead types; however, BGLAP was significantly
higher in ALP-modified beads cultured for 21 days in OM (p 0.001, Tukey’s multiple com-
parison test).
Sclerostin (SOST) is a marker specific for osteocytes/late osteoblasts and is induced after
BGLAP [29]. Indeed, in cells cultured in OM in both bead types SOSTmRNA was highly ex-
pressed (Fig. 4E), many hundred-fold increased compared with cells induced to differentiate
on plastic. After 21 days, SOSTmRNA was significantly higher in unmodified alginate beads
Fig 4. SEMmicrographs of collagen fibrils in beads cultured in osteogenic medium. (A, C) low and high magnification of the space close to a cell
producing collagen in ALPmodified beads (ALP+). Mineral crystals similar to those shown in Fig. 2 are indicated by *; (B, D) low and high magnification
micrographs of the space close to a cell producing collagen in unmineralized beads. Images were collected at 21 days post encapsulation.
doi:10.1371/journal.pone.0120374.g004
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Fig 5. Relative mRNA expression of osteoblast/ osteocyte markers.MSCs were cultured in unmodified (no ALP), ALP-modified (ALP) alginate beads or
on traditional culture plates (2D). Samples were cultured in either growth medium (GM) or osteogenic medium (OM) for 21 days post encapsulation. RUNX2
(A), Osterix (SP7) (B), COL1A1 (C), and sclerostin (SOST) (E) mRNA expression are relative to mRNA expression in cells cultured on traditional culture
plates in osteogenic medium for 7 days. Osteocalcin (BGLAP) (D) and DMP1 (F) mRNA expressions are relative to mRNA expression in cells in unmodified
alginate beads cultured in growth medium for 7 days post encapsulation. ND = not detected.
doi:10.1371/journal.pone.0120374.g005
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compared with ALP-beads (p 0.001, Tukey’s multiple comparison test). Moreover, the
mRNA expression of dentin matrix protein 1 (DMP1), an extracellular matrix protein express-
ed by osteocytes, was highly expressed in encapsulated cells cultured in OM, and was also ex-
pressed by cells in beads cultured in growth medium (Fig. 5F). After 21 days, DMP1 was higher
in ALP-modified beads compared with unmodified beads (p 0.05, Tukey’s multiple compari-
son test), whereas there was no difference in DMP1 expression in cells cultured in GM. Cells
cultured in osteogenic conditions on plastic did not express DMP1. To further verify that the
cells differentiated in osteogenic direction, we measured alkaline phosphatase (ALP) activity by
an enzymatic assay. Indeed, alkaline phosphatase activity increased in cells cultured in OM
compared with GM in both ALP-modified and unmodified beads (p0.01, Sidak’s multiple
comparison test) (Fig. 6). ALP-activity also appeared higher in unmodified beads compared
with modified beads cultured in OM (p 0.05, Sidak’s multiple comparison test), but not in
GM.
Taken together, these results suggest that both unmodified and ALP-modified beads confer
a 3D environment that promotes osteoblast differentiation and can support an osteocytic phe-
notype in vitro. The bead type, however, does not seem to have a major influence on osteogenic
differentiation. Similar results were obtained for a second donor (S2 Fig.).
Discussion
The main finding of this study is that enzymatic mineralization of alginate beads is compatible
with the survival and osteogenic differentiation of encapsulated human MSC. Moreover, both
ALP-modified and unmodified alginate beads promote osteogenic differentiation of MSC com-
pared to differentiation in 2D. A greater extent of mineral deposition was found in the ALP-
modified beads; hence these beads have the potential to serve as a bone substitute in
tissue engineering.
Here, we show that human bone marrow-derived MSC cultured in both unmodified and
ALP-modified alginate beads were efficiently induced to differentiate in osteogenic direction.
These findings are in line with what has been shown for alginate beads in previous studies
[30, 31]. However, the enzymatically mineralized alginate gels differs from already described
models in that the matrix itself is bone-like as the mineral phase in previous studies has been
characterized to be HA [19]. HA not only makes the material stronger and is more similar to
bone, but it also may facilitate bone formation, both important features in bone regeneration
scaffolds [32]. There are several alginate models where different types of calcium phosphates
have been incorporated including HA [33] and calcium phosphate cement (CPC) [34–37].
These models all support growth and survival of pre-osteoblasts, but in contrast to our model
the cells are (often) prepared separately from the minerals. Co-immobilizing cells with alkaline
phosphatase (ALP) for gradual mineralization of the microenvironment is fundamentally dif-
ferent from seeding MSC into a macroporous scaffold and may provide a truer bone-
like environment.
Another alginate model is the widely used RGD-model. RGD-modified alginate, in which
the RGD peptides create attachment points for the encapsulated cells, has been shown to con-
trol phenotype, enhance cell-matrix interactions and promote differentiation into mature oste-
oblasts from mouse pre-osteoblasts [38], human pre-osteoblasts [39] and human MSC [30]
The focus of these studies has been on cell characterization and although positive staining for
calcium deposits has been shown in the RGD-alginate [30], no further material characteriza-
tion has been proved. The enzymatic mineralization of the alginate gel allows for an even distri-
bution of minerals throughout the matrix, where the deposition can be easily controlled by
varying the concentrations of precursors and varying pH, temperature and buffer [19].
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Mineralization of the ALP-modified beads continued for the duration of the study, regardless
of culture medium. The mineral granules were in the 100 nm range and dispersed evenly in the
alginate network. ALP activity assay performed at day 9 revealed that ALP was active only in
cells cultured in osteogenic medium (data not shown). At day 21, unmodified beads cultured in
osteogenic medium was mineralized, nevertheless to a much lower degree than ALP-modified
samples regardless of culture medium. In the unmodified beads mineralization is a much
slower process, only scarcely visible at day 21 post encapsulation. Hence, it seems that initial
mineralization by the encapsulated ALP is important for further mineral deposition.
Interestingly, beads mineralized by encapsulated enzyme were quickly destabilized if the cal-
cium concentration in the culture medium was too low. This could be stabilized by addition of
7.5 mM calcium to the culture medium. The mechanism of destabilization is likely due to the
continuous activity of the enzyme liberating phosphate ions after the initial 48 hour minerali-
zation period. As calcium is only present at low concentrations in the medium during the pro-
longed culture period, the calcium-alginate cross-links are destabilized and calcium ions bind,
preferentially, to phosphate ions to form calcium phosphate. The proposed mechanism could
provide a means of destabilizing the beads in vivo post implantation, which may be beneficial
for the regeneration of bone at the implant site.
The encapsulated MSCs remained highly viable after encapsulation and for the duration of the
study period (21 days). The high viability obtained in this study may be partially due to the small
bead size making the nutrient, oxygen and waste distribution route short. This is an advantage as
it will avoid the buildup of toxic waste products in the matrix. Additionally; the encapsulated cells
remained metabolically active for the duration of the study. Although proliferation was not quan-
tified in the present study no obvious increase in cell numbers was observed by visual inspection
of encapsulated cells. However, an increase in metabolic activity in cells cultured in growth medi-
um compared to the cells cultured in osteogenic medium probably reflects an increase in
Fig 6. Alkaline phosphatase activity in cells cultured in ALP-modified or unmodified beads for 9 days
as indicated. p values indicate statistical significant differences by Sidak’s multiple comparison test.
doi:10.1371/journal.pone.0120374.g006
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proliferation of undifferentiated osteoblasts compared with more mature cells [23]. Our results
are in accordance with a study where MSC were seeded on top of BCP particles and cultured in ei-
ther osteogenic or growth medium for 21 days. Results show that proliferation is lowest for cells
cultured in osteogenic medium, regardless of modification, and highest when cultured in 2D [40].
Gene expression analyses indicated that the MSCs differentiated into mature osteoblasts and
osteocytes. Early osteoblast markers were present in all samples, and the mRNA levels were
highest in MSC cultured in beads in osteogenic medium, lower in MSC cultured on plates in os-
teogenic medium, and lowest in beads cultured in growth medium. Late osteoblast/osteocyte
markers (BGLAP, DMP1 and SOST) were expressed only by cells in beads, which may infer that
the 3D environment itself promote differentiation. Supporting this, we found that the osteocyte
marker DMP1 was only detectable in cells cultured in beads. Hence, the mineralized beads
might resemble osteoid tissue where osteoblasts get buried into the tissue and become osteo-
cytes [5]. Even though osteocytes are the most abundant cell in bone, they are, by far, the least
studied. Until recently they were considered to be silent bystanders, but they have been shown
to be important regulators of mineralization, sensing mechanical strain and maintaining bone
homeostasis [41]. This highlights the importance of developing tools to study osteocytes in
vitro. The differentiation towards osteocytes in bone tissue engineering systems is scarcely de-
scribed. Our results suggest that mineralized alginate beads may be used as a model system.
In summary, our results demonstrate that enzymatically mineralized alginate beads are cell
compatible, promote hMSC differentiation towards osteoblasts and further mineralization of
the alginate matrix. Hence this is interesting for bone tissue engineering. Collagen type I fibrils
were found inside beads cultured in osteogenic medium, and cells expressed both BGLAP and
DMP1, which are both important for the mineralization of bone [42, 43]. Moreover, the algi-
nate beads can also be used as tool to study osteoblastogenesis and osteocyte function in vitro.
Supporting Information
S1 Fig. Viability of MSCs in alginate beads cultured in growth medium. Live/dead stained
cells were visualized using confocal microscopy (LSM 510 META FCS, Zeiss). Left images:
Confocal cross sections through overlaid transmitted light of hMSCs in alginate beads; Right
images: three dimensional reconstructions of cross sections through the beads. Live cells appear
green, dead cells appear red. Scale bar 500μm.
(TIF)
S2 Fig. Relative mRNA expression of osteoblast/ osteocyte markers.MSCs were cultured in
unmodified (wo ALP), ALP-modified (ALP) alginate beads (3D) or on traditional culture
plates (2D). Samples were cultured in either growth medium (GM) or differentiation medium
(DM) for 21 days post encapsulation. mRNA expression of RUNX2 (A), COL1A1 (C) and
osterix (B) are relative to cells cultured on traditional culture plates cultured in DM at d7 post
encapsulation. DMP1 (D) mRNA expression is relative to mRNA expression in cells in unmod-
ified alginate beads cultured in DM at d7 post encapsulation. ND = not detected.
(TIF)
S1 Table. Immunophenotype of MSC purchased from Lonza Inc.
(TIF)
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